Plaque psoriasis
Bausch Health Americas Inc. is involved in clinical research focused on plaque psoriasis, with attention to dermatologic treatment options for pediatric patients and the management of moderate to severe skin disease.
- Topical dermatology
- Pediatric psoriasis
- Inflammatory skin disease
The sponsored studies center on skin-directed therapies for psoriasis, including evaluation of cutaneous absorption and treatment-related systemic exposure.
Endocrine safety
The sponsor also has research interest in hypothalamic-pituitary-adrenal axis effects associated with topical psoriasis therapies, reflecting attention to endocrine safety considerations in dermatologic care.
- HPA axis suppression
- Systemic corticosteroid exposure
- Topical treatment safety
These studies examine whether topical corticosteroid-based regimens may influence adrenal function during use in children with psoriasis.
Combination topical therapy
Bausch Health Americas Inc. is active in research on combination topical formulations for inflammatory skin conditions, including products that pair a corticosteroid with a vitamin D analog.
- Combination dermatologic formulations
- Corticosteroid-based therapy
- Vitamin D analog therapy
This area of interest supports clinical assessment of skin-targeted treatments designed for psoriatic plaques and related inflammatory lesions.
